[144] UMB Financial Corporation SEC Filing

Rhea-AI Filing Summary

UMB Financial Corporation (UMBFP) Form 144 — This notice reports a proposed sale of 750 shares of common stockapproximate sale date of 08/25/2025. The filing lists an aggregate market value of $90,727.00 and shows 48,530,798 shares outstanding for the issuer. The shares to be sold were acquired through restricted stock vesting earlier in 2025: 542 shares on 01/27/2025, 146 shares on 02/09/2025, and 62 shares on 02/11/2025, all from UMB Financial. The filer certifies they are not aware of undisclosed material adverse information about the issuer.

Positive

• Planned sale disclosed with broker and approximate sale date provided, meeting Rule 144 disclosure requirements
• Acquisitions documented: restricted stock vesting events on 01/27/2025 (542 shares), 02/09/2025 (146 shares), and 02/11/2025 (62 shares)

Negative

• None.

Insights

Securities Analyst

TL;DR: Routine Rule 144 notice for a small planned sale of vested restricted shares; unlikely to be material to shareholders.

The filing documents a proposed sale of 750 common shares acquired through recent restricted stock vesting events. Compared with the reported 48,530,798 shares outstanding, the quantity represents a negligible proportion of the float and the stated aggregate value is modest. The use of a broker (Merrill Lynch) and the seller's attestation regarding undisclosed material information align with standard compliance practice for an insider sale under Rule 144.

Corporate Governance Expert

TL;DR: Disclosure is procedural and follows Rule 144 requirements; no governance red flags are evident in the notice.

The notice clearly identifies acquisition dates and nature (restricted stock vesting) and provides required sale timing and broker details. There is no report of other sales in the past three months. The signature attestation regarding material adverse information is included, which is a customary representation for such filings.

Form 144 Filer Information	UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 Form 144 NOTICE OF PROPOSED SALE OF SECURITIES PURSUANT TO RULE 144 UNDER THE SECURITIES ACT OF 1933
FORM 144

144: Filer Information

Filer CIK
Filer CCC
Is this a LIVE or TEST Filing?	LIVE TEST
Submission Contact Information
Name
Phone
E-Mail Address

144: Issuer Information

Name of Issuer

SEC File Number

Address of Issuer

Phone

Name of Person for Whose Account the Securities are To Be Sold

See the definition of "person" in paragraph (a) of Rule 144. Information is to be given not only as to the person for whose account the securities are to be sold but also as to all other persons included in that definition. In addition, information shall be given as to sales by all persons whose sales are required by paragraph (e) of Rule 144 to be aggregated with sales for the account of the person filing this notice.

Relationship to Issuer

144: Securities Information

Title of the Class of Securities To Be Sold	Name and Address of the Broker	Number of Shares or Other Units To Be Sold	Aggregate Market Value	Number of Shares or Other Units Outstanding	Approximate Date of Sale	Name the Securities Exchange
Common	Merrill Lynch 8890 Lyra Drive, 5th Floor Columbus OH 43240	750	90727.00	48530798	08/25/2025	NASDAQ

Furnish the following information with respect to the acquisition of the securities to be sold and with respect to the payment of all or any part of the purchase price or other consideration therefor:

144: Securities To Be Sold

Title of the Class	Date you Acquired	Nature of Acquisition Transaction	Name of Person from Whom Acquired	Is this a Gift?	Date Donor Acquired	Amount of Securities Acquired	Date of Payment	Nature of Payment *
Common	01/27/2025	Restricted Stock Vesting	UMB Financial			542	01/27/2025	NA
Common	02/09/2025	Restricted stock vest	UMB Financial			146	02/09/2025	NA
Common	02/11/2025	restricted stock vest	UMB Financial			62	02/11/2025	na

* If the securities were purchased and full payment therefor was not made in cash at the time of purchase, explain in the table or in a note thereto the nature of the consideration given. If the consideration consisted of any note or other obligation, or if payment was made in installments describe the arrangement and state when the note or other obligation was discharged in full or the last installment paid.

Furnish the following information as to all securities of the issuer sold during the past 3 months by the person for whose account the securities are to be sold.

144: Securities Sold During The Past 3 Months

Nothing to Report

144: Remarks and Signature

Remarks

Date of Notice

ATTENTION:

The person for whose account the securities to which this notice relates are to be sold hereby represents by signing this notice that he does not know any material adverse information in regard to the current and prospective operations of the Issuer of the securities to be sold which has not been publicly disclosed. If such person has adopted a written trading plan or given trading instructions to satisfy Rule 10b5-1 under the Exchange Act, by signing the form and indicating the date that the plan was adopted or the instruction given, that person makes such representation as of the plan adoption or instruction date.

Signature

ATTENTION: Intentional misstatements or omission of facts constitute Federal Criminal Violations (See 18 U.S.C. 1001)

FAQ

What does the UMBFP Form 144 report?

The filing reports a proposed sale of 750 common shares acquired via restricted stock vesting, with an approximate sale date of 08/25/2025 through Merrill Lynch.

How many shares outstanding does UMBFP show in this filing?

The filing lists 48,530,798 shares outstanding for the issuer.

What is the aggregate market value of the shares to be sold in the UMBFP filing?

The aggregate market value reported for the 750 shares is $90,727.00.

How were the shares acquired that are to be sold under Rule 144?

All reported shares were acquired through restricted stock vesting from UMB Financial on 01/27/2025, 02/09/2025, and 02/11/2025.

Does the filing report any other sales in the past three months?

The filing states Nothing to Report for securities sold during the past three months.